🔎 Trials Near Me

Akèy › Kansè pwostat rezistan a kastasyon › Pennsylvania › Philadelphia

Etid klinik pou Kansè pwostat rezistan a kastasyon nan Philadelphia, PA

4 etid pou Kansè pwostat rezistan a kastasyon ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Ap rekriteFaz 3
  • MidLantic Urology, Bala-Cynwyd · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07225946

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Ap rekriteFaz 3
  • Penn Medicine Abramson Cancer Center, Philadelphia
  • MidLantic Urology, Bala-Cynwyd · 5 mi lwen
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07164443

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Ap rekriteFaz 1/2
  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04104776

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Ap rekriteFaz 1
  • Thomas Jefferson University Honickman Center, Philadelphia
Laj 18 a 100 · Gason · Mizajou Aug 13, 2026 · NCT05519449

Etid Kansè pwostat rezistan a kastasyon nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.